Cargando…
The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies
BACKGROUND: Hereditary medullary thyroid carcinoma (MTC) is caused by germ-line gain of function mutations in the RET proto-oncogene, and a phenotypic variability among carriers of the same mutation has been reported. We recently observed this phenomenon in a large familial MTC (FMTC) family carryin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373282/ https://www.ncbi.nlm.nih.gov/pubmed/25887804 http://dx.doi.org/10.1186/s13023-015-0231-z |
_version_ | 1782363316877787136 |
---|---|
author | Colombo, Carla Minna, Emanuela Rizzetti, Maria Grazia Romeo, Paola Lecis, Daniele Persani, Luca Mondellini, Piera Pierotti, Marco A Greco, Angela Fugazzola, Laura Borrello, Maria Grazia |
author_facet | Colombo, Carla Minna, Emanuela Rizzetti, Maria Grazia Romeo, Paola Lecis, Daniele Persani, Luca Mondellini, Piera Pierotti, Marco A Greco, Angela Fugazzola, Laura Borrello, Maria Grazia |
author_sort | Colombo, Carla |
collection | PubMed |
description | BACKGROUND: Hereditary medullary thyroid carcinoma (MTC) is caused by germ-line gain of function mutations in the RET proto-oncogene, and a phenotypic variability among carriers of the same mutation has been reported. We recently observed this phenomenon in a large familial MTC (FMTC) family carrying the RET-S891A mutation. Among genetic modifiers affecting RET-driven MTC, a role has been hypothesized for RET-G691S non-synonymous polymorphism, though the issue remains controversial. Aim of this study was to define the in vitro contribution of RET-G691S to the oncogenic potential of the RET-S891A, previously shown to harbour low transforming activity. METHODS: The RET-S891A and RET-G691S/S891A mutants were generated by site-directed mutagenesis, transiently transfected in HEK293T cells and stably expressed in NIH3T3 cells. Their oncogenic potential was defined by assessing the migration ability by wound healing assay and the anchorage-independent growth by soft agar assay in NIH3T3 cells stably expressing either the single or the double mutants. Two RET-S891A families were characterised for the presence of RET-G691S. RESULTS: The functional studies demonstrated that RET-G691S/S891A double mutant displays a higher oncogenic potential than RET-S891A single mutant, assessed by focus formation and migration ability. Moreover, among the 25 RET-S891A carriers, a trend towards an earlier age of diagnosis was found in the MTC patients harboring RET-S891A in association with RET-G691S. CONCLUSIONS: We demonstrate that the RET-G691S non-synonymous polymorphism enhances in vitro the oncogenic activity of RET-S891A. Moreover, an effect on the phenotype was observed in the RET-G691S/S891A patients, thus suggesting that the analysis of this polymorphism could contribute to the decision on the more appropriate clinical and follow-up management. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0231-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4373282 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43732822015-03-26 The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies Colombo, Carla Minna, Emanuela Rizzetti, Maria Grazia Romeo, Paola Lecis, Daniele Persani, Luca Mondellini, Piera Pierotti, Marco A Greco, Angela Fugazzola, Laura Borrello, Maria Grazia Orphanet J Rare Dis Research BACKGROUND: Hereditary medullary thyroid carcinoma (MTC) is caused by germ-line gain of function mutations in the RET proto-oncogene, and a phenotypic variability among carriers of the same mutation has been reported. We recently observed this phenomenon in a large familial MTC (FMTC) family carrying the RET-S891A mutation. Among genetic modifiers affecting RET-driven MTC, a role has been hypothesized for RET-G691S non-synonymous polymorphism, though the issue remains controversial. Aim of this study was to define the in vitro contribution of RET-G691S to the oncogenic potential of the RET-S891A, previously shown to harbour low transforming activity. METHODS: The RET-S891A and RET-G691S/S891A mutants were generated by site-directed mutagenesis, transiently transfected in HEK293T cells and stably expressed in NIH3T3 cells. Their oncogenic potential was defined by assessing the migration ability by wound healing assay and the anchorage-independent growth by soft agar assay in NIH3T3 cells stably expressing either the single or the double mutants. Two RET-S891A families were characterised for the presence of RET-G691S. RESULTS: The functional studies demonstrated that RET-G691S/S891A double mutant displays a higher oncogenic potential than RET-S891A single mutant, assessed by focus formation and migration ability. Moreover, among the 25 RET-S891A carriers, a trend towards an earlier age of diagnosis was found in the MTC patients harboring RET-S891A in association with RET-G691S. CONCLUSIONS: We demonstrate that the RET-G691S non-synonymous polymorphism enhances in vitro the oncogenic activity of RET-S891A. Moreover, an effect on the phenotype was observed in the RET-G691S/S891A patients, thus suggesting that the analysis of this polymorphism could contribute to the decision on the more appropriate clinical and follow-up management. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0231-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-01 /pmc/articles/PMC4373282/ /pubmed/25887804 http://dx.doi.org/10.1186/s13023-015-0231-z Text en © Colombo et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Colombo, Carla Minna, Emanuela Rizzetti, Maria Grazia Romeo, Paola Lecis, Daniele Persani, Luca Mondellini, Piera Pierotti, Marco A Greco, Angela Fugazzola, Laura Borrello, Maria Grazia The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies |
title | The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies |
title_full | The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies |
title_fullStr | The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies |
title_full_unstemmed | The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies |
title_short | The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies |
title_sort | modifier role of ret-g691s polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373282/ https://www.ncbi.nlm.nih.gov/pubmed/25887804 http://dx.doi.org/10.1186/s13023-015-0231-z |
work_keys_str_mv | AT colombocarla themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT minnaemanuela themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT rizzettimariagrazia themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT romeopaola themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT lecisdaniele themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT persaniluca themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT mondellinipiera themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT pierottimarcoa themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT grecoangela themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT fugazzolalaura themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT borrellomariagrazia themodifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT colombocarla modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT minnaemanuela modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT rizzettimariagrazia modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT romeopaola modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT lecisdaniele modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT persaniluca modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT mondellinipiera modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT pierottimarcoa modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT grecoangela modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT fugazzolalaura modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies AT borrellomariagrazia modifierroleofretg691spolymorphisminhereditarymedullarythyroidcarcinomafunctionalcharacterizationandexpressionpenetrancestudies |